Cargando…
291 Efficacy and safety of telavancin in the treatment ofram-positive bloodstream infections in cancer patients
Autores principales: | Chaftari, Anne-Marie, Hachem, Ray, Jordan, Mary, Garoge, Kumait, Al Hamal, Zainab, El Zakhem, Aline, Viola, George M., Granwwehr, Bruno, Gagel, Andrew, Jiang, Ying, Al Shuaibi, Munirah, Raad, Issam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781705/ http://dx.doi.org/10.1093/ofid/ofu052.157 |
Ejemplares similares
-
1709 Mycobacterium Arupense in Cancer Patients: A Commensal Organism or a Pathogen?
por: Jordan, Mary, et al.
Publicado: (2014) -
Role of Procalcitonin and Interleukin-6 in Predicting Cancer, and Its Progression Independent of Infection
por: Chaftari, Anne-Marie, et al.
Publicado: (2015) -
475 Telavancin (TLV) In vitro Activity Tested Against a USA Collection of Methicillin-resistant Staphylococcus aureus (MRSA), Including a Multidrug-resistant (MDR) Subset (2011-2013)
por: Mendes, Rodrigo E., et al.
Publicado: (2014) -
The use of minocycline-rifampin coated central venous catheters for exchange of catheters in the setting of staphylococcus aureus central line associated bloodstream infections
por: Chaftari, Anne-Marie, et al.
Publicado: (2014) -
715 Impact of Fluoroquinolone Resistance on Community-Onset Gram-Negative Bloodstream Infections
por: Brigmon, Matthew, et al.
Publicado: (2014)